Latest 30 News in the Life Sciences Industry
GlobeNewswire
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
13 Apr 2026
GlobeNewswire
Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)
13 Apr 2026
GlobeNewswire
Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
13 Apr 2026
GlobeNewswire
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
13 Apr 2026
PR Newswire Association LLC.
Data Published in Journal of Diabetes Science and Technology from First-in-Human Study Evaluating the Feasibility of Integrated Insulin Delivery and Glucose Monitoring Using an Insulin Patch Pump
10 Apr 2026
GlobeNewswire
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
10 Apr 2026
PR Newswire Association LLC.
Hamilton Dissolved Oxygen Sensors Achieve North American Ex Approval for Hazardous Environments
09 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
09 Apr 2026
GlobeNewswire
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development
09 Apr 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09 Apr 2026
GlobeNewswire
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09 Apr 2026
GlobeNewswire
Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program
09 Apr 2026
GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
08 Apr 2026
GlobeNewswire
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
07 Apr 2026
GlobeNewswire
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
07 Apr 2026
PR Newswire Association LLC.
Peri Launches First Wearable Device Designed Specifically for Perimenopause
02 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]
01 Apr 2026
PR Newswire Association LLC.
Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%, Aiming to Achieve"RMB10 Billion in Profit"
31 Mar 2026
PR Newswire Association LLC.
Chinese Medical Association Publishing House Co., Ltd. Sheds Light on New Noninvasive Clues to Detect Portal Hypertension
30 Mar 2026
PR Newswire Association LLC.
Regulatory Expert Files Citizen Petition Urging FDA to Address 13-Year Delay in Conflict-of-Interest Policy
27 Mar 2026
PR Newswire Association LLC.
FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
27 Mar 2026
PR Newswire Association LLC.
Renibus Therapeutics Announces Participation at the 25th Annual Needham Virtual Healthcare Conference
26 Mar 2026
PR Newswire Association LLC.
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
26 Mar 2026
Upcoming Events All Events
- April 2026
- BioTrinity 2026
- Oslo: 7th Norwegian Life Science Investor Partnering Day
- Seattle: Life Science Innovation Northwest 2026